The therapeutic potential of epigenetic manipulation during infectious diseases

Anju M. Philip,Alexandra Binnie,Claudia C. dos Santos
DOI: https://doi.org/10.1016/b978-0-12-816422-8.00009-x
2020-01-01
Abstract:The term “epigenetics” was coined in the early 20th century to link the field of developmental biology with that of genetics. It is broadly defined as the sum of all mechanisms necessary for the unfolding of the genetic program. Aberrant gene expression secondary to epigenetic regulation has been associated with various disease states and identified as the causative agent of pathology in specific diseases. In the field of infectious diseases, recent evidence suggests that pathogens target the host epigenome to facilitate immune evasion and survival. Moreover, the host response to invasion is orchestrated, at least in part, at the level of epigenetics. The discovery of epigenetic modifiers targeting DNA methylation and histone-modifying enzymes presents a unique opportunity for therapy heralding a new era of host-immune targeted therapeutics. In this chapter, we review current knowledge on the role of epigenetic modifications during infection with a special focus on histone modifications and their impact on the host response and potential opportunities for novel therapeutics.
What problem does this paper attempt to address?